CTLA4 and prostate carcinoma: This suggests that the regulatory responses we identified in the transplant, NIMA, and prostate cancer patients may have been relying on iTr35 cells, whereas the responses we identified to collagen V were nTregs, and suggests that potentially CTLA-4 and IL-35-dependency may be a technique that can be used to identify this population of inducible regulatory cells.